{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:05:57Z","timestamp":1793505957285,"version":"4.5.0"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejphar.2023.175776","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:29:44Z","timestamp":1684153784000},"page":"175776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms"],"prefix":"10.1016","volume":"951","author":[{"given":"Hanan S.","family":"Althagafy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa K. Abd","family":"El-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa K.","family":"Abd-alhameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-2342","authenticated-orcid":false,"given":"Emad H.M.","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175776_bib1","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.4049\/jimmunol.165.9.5227","article-title":"Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways","volume":"165","author":"Ahmed","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0092-8674(94)90235-6","article-title":"Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway","volume":"77","author":"Akira","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175776_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119433","article-title":"Regulation of IL-6\/STAT-3\/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: novel mechanistic insight","volume":"276","author":"Ali","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp078166","article-title":"Hematopoietic-cell transplantation at 50","volume":"357","author":"Appelbaum","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1986.tb05545.x","article-title":"Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum","volume":"63","author":"Atkinson","year":"1986","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2023.175776_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrgastro.2014.201","article-title":"IBD pathogenesis in 2014: molecular pathways controlling barrier function in IBD","volume":"12","author":"Atreya","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2023.175776_bib7","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.drudis.2019.06.017","article-title":"Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment","volume":"24","author":"Bailly","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2023.175776_bib167","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5455\/msm.2016.28.454-458","article-title":"Open clinical trial on using nifuroxazide compared to probiotics in treating acute diarrhoeas in adults","volume":"28","author":"Begovic","year":"2016","journal-title":"Mater. Soc. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000402883","article-title":"The role of the interstitium of the renal cortex in renal disease","volume":"16","author":"Bohle","year":"1979","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175776_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2023.175776_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3748\/wjg.v17.i5.547","article-title":"Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases","volume":"17","author":"Bouguen","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2023.175776_bib12","first-page":"469","article-title":"[Double-blind controlled study of the efficacy of nifuroxazide versus placebo in the treatment of acute diarrhea in adults]","volume":"13","author":"Bour\u00e9e","year":"1989","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0035-9203(87)90053-8","article-title":"Double-blind study of traveller's diarrhoea using Nifuroxazide","volume":"81","author":"Bour\u00e9e","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejphar.2023.175776_bib14","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.23828","article-title":"Targeting the tumor microenvironment: JAK-STAT3 signaling","volume":"2","author":"Bournazou","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1016\/j.ejphar.2023.175776_bib15","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2023.175776_bib16","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1681\/ASN.2009070721","article-title":"Mouse models of diabetic nephropathy","volume":"20","author":"Brosius","year":"2009","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.ejphar.2023.175776_bib17","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib18","first-page":"123","article-title":"[Effects of nifuroxazide on fecal flora in healthy subjects]","volume":"44","author":"Buisson","year":"1989","journal-title":"Therapie"},{"key":"10.1016\/j.ejphar.2023.175776_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.175776_bib20","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.ejca.2009.05.009","article-title":"Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant","volume":"45","author":"Caini","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.175776_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ibd.20342","article-title":"Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease","volume":"14","author":"Carey","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2023.175776_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/10428199809057555","article-title":"Stat3 and G-CSF-induced myeloid differentiation","volume":"30","author":"Chakraborty","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejphar.2023.175776_bib24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.ejphar.2023.175776_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000486422","article-title":"Heterogeneity of thyroid cancer","volume":"85","author":"Chmielik","year":"2018","journal-title":"Pathobiology"},{"key":"10.1016\/j.ejphar.2023.175776_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7748\/ns.2021.e11709","article-title":"Diabetes mellitus: an overview of the types, symptoms, complications and management","volume":"37","author":"Cloete","year":"2022","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.ejphar.2023.175776_bib28","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib29","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","article-title":"Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis","volume":"19","author":"Cutler","year":"2001","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejphar.2023.175776_bib30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis","volume":"365","author":"Danese","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib31","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1182\/blood-2008-08-175448","article-title":"Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease","volume":"113","author":"Das","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib32","first-page":"52","article-title":"Breast cancer statistics, 2013","volume":"64","author":"DeSantis","year":"2014","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2023.175776_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ki.2013.113","article-title":"NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy","volume":"84","author":"Du","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2023.175776_bib34","first-page":"3727","article-title":"Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancer","volume":"22","author":"Duffour","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2023.175776_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hoc.2009.03.013","article-title":"The classification of cutaneous melanoma","volume":"23","author":"Duncan","year":"2009","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2023.175776_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103433","article-title":"The interplay of the inhibitory effect of nifuroxazide on NF-\u03baB\/STAT3 signaling attenuates acetic acid-induced ulcerative colitis in rats","volume":"79","author":"El-Far","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175776_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26226858","article-title":"Nifuroxazide mitigates angiogenesis in ehlrich's solid carcinoma: molecular docking, bioinformatic and experimental studies on inhibition of Il-6\/Jak2\/stat3 signaling","volume":"26","author":"El-Sherbiny","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.175776_bib38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2174\/1871520619666190118120030","article-title":"Anti-diarrheal drug repositioning in tumour cell cytotoxicity","volume":"19","author":"Elloumi-Mseddi","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejphar.2023.175776_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/15376516.2018.1459995","article-title":"Renoprotective effect of nifuroxazide in diabetes-induced nephropathy: impact on NF\u03baB, oxidative stress, and apoptosis","volume":"28","author":"Elsherbiny","year":"2018","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ejphar.2023.175776_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41388-019-1009-x","article-title":"Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F","volume":"39","author":"Esteves","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2023.175776_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","article-title":"Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study","volume":"20","author":"Fassas","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejphar.2023.175776_bib42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.ejphar.2023.175776_bib43","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: globocan 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.175776_bib44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.mayocp.2019.01.018","article-title":"Ulcerative colitis","volume":"94","author":"Feuerstein","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2023.175776_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.22227","article-title":"Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant","volume":"87","author":"Fidler","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2023.175776_bib46","first-page":"85","article-title":"Septic cardiomyopathy: a distinct histopatho-logical entity","volume":"1","author":"Figueiredo","year":"2015","journal-title":"Frontiers"},{"key":"10.1016\/j.ejphar.2023.175776_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","article-title":"Histopathology of diabetic nephropathy","volume":"27","author":"Fioretto","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175776_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-022-01946-6","article-title":"Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study","volume":"23","author":"Gan","year":"2022","journal-title":"Respiration Research"},{"key":"10.1016\/j.ejphar.2023.175776_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib50","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/cncr.21359","article-title":"Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies","volume":"104","author":"Gennari","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2023.175776_bib51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopha.2018.11.127","article-title":"An update on Drug Repurposing: Re-written saga of the drug's fate","volume":"110","author":"Gns","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2023.175776_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","article-title":"Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis","volume":"13","author":"Greuter","year":"2019","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2023.175776_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semcdb.2008.06.005","article-title":"The function of Stat3 in tumor cells and their microenvironment","volume":"19","author":"Groner","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5152\/TJAR.2017.93753","article-title":"Changing definitions of sepsis","volume":"45","author":"G\u00fcl","year":"2017","journal-title":"Turkish journal of anaesthesiology and reanimation"},{"key":"10.1016\/j.ejphar.2023.175776_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00002727-200404000-00003","article-title":"Pathophysiology of diabetes mellitus","volume":"27","author":"Guthrie","year":"2004","journal-title":"Crit. Care Nurs. Q."},{"key":"10.1016\/j.ejphar.2023.175776_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.dld.2006.09.016","article-title":"Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy","volume":"39","author":"Hassan","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119241","article-title":"Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3\/NF-\u03baB signaling, oxidative stress and inflammation","volume":"272","author":"Hassan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00535-005-1744-3","article-title":"Novel pathophysiological concepts of inflammatory bowel disease","volume":"41","author":"Hibi","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2023.175776_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031106","article-title":"STAT3\/5 inhibitors suppress proliferation in bladder cancer and enhance oncolytic adenovirus therapy","volume":"21","author":"Hindupur","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib60","first-page":"48","volume":"vol. 50","author":"Hu","year":"2019"},{"key":"10.1016\/j.ejphar.2023.175776_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2023.175776_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2017.06.001","article-title":"The JAK\/STAT3 axis: a comprehensive drug target for solid malignancies","volume":"45","author":"Huynh","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0145-2126(01)00003-0","article-title":"STAT isoforms: mediators of STAT specificity or leukemogenesis?","volume":"25","author":"Ilaria","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2023.175776_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-5890(00)00018-3","article-title":"The jak-STAT pathway","volume":"37","author":"Imada","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib65","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2002-10-3170","article-title":"Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans","volume":"102","author":"James","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib67","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2023.175776_bib68","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2023.175776_bib69","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.3892\/mmr.2017.7825","article-title":"Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: old drug, new use","volume":"16","author":"Jia","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2023.175776_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.399","article-title":"Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation","volume":"7","author":"Jia","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib71","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","article-title":"Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines","volume":"19","author":"Jin","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2023.175776_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2023.175776_bib73","doi-asserted-by":"crossref","first-page":"s41","DOI":"10.7861\/clinmedicine.18-2-s41","article-title":"Recent advances in the management of lung cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib74","doi-asserted-by":"crossref","first-page":"745","DOI":"10.32383\/appdr\/105805","article-title":"Safety of oral nifuroxazide\u2013analysis of data from a spontaneous reporting system","volume":"76","author":"Karlowicz-Bodalska","year":"2019","journal-title":"Acta Poloniae Pharmaceutica-Drug Research"},{"key":"10.1016\/j.ejphar.2023.175776_bib75","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease","volume":"68","author":"Kernan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117610","article-title":"Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK\/caspase-8\/TRAIL activation in rats","volume":"252","author":"Khodir","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117907","article-title":"A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4\/NLPR3\/IL-1\u03b2 signaling interruption","volume":"256","author":"Khodir","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib78","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","article-title":"Obstructive nephropathy and renal fibrosis","volume":"283","author":"Klahr","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2023.175776_bib79","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2023.175776_bib80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1440-1797.2007.00881.x","article-title":"Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction","volume":"12","author":"Kuratsune","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.ejphar.2023.175776_bib82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bdd.2510070504","article-title":"Comparative physiological disposition of two nitrofuran anti-microbial agents","volume":"7","author":"Labaune","year":"1986","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.ejphar.2023.175776_bib83","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2023.175776_bib84","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2672.1985.tb01710.x","article-title":"In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice","volume":"58","author":"Leonard","year":"1985","journal-title":"J. Appl. Bacteriol."},{"key":"10.1016\/j.ejphar.2023.175776_bib85","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1089-3261(03)00101-6","article-title":"Primary biliary cirrhosis\u2014presentation and diagnosis","volume":"7","author":"Leuschner","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib86","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib87","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do?","volume":"109","author":"Levy","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175776_bib88","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.blre.2016.03.001","article-title":"Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives","volume":"30","author":"Li Pira","year":"2016","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejphar.2023.175776_bib89","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.prp.2005.06.004","article-title":"Cholangitis: a histologic classification based on patterns of injury in liver biopsies","volume":"201","author":"Li","year":"2005","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejphar.2023.175776_bib90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12865-019-0322-z","article-title":"Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib91","doi-asserted-by":"crossref","first-page":"39394","DOI":"10.1039\/C9RA06527J","article-title":"Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells","volume":"9","author":"Liu","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejphar.2023.175776_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174042","article-title":"Nifuroxazide improves insulin secretion and attenuates high glucose-induced inflammation and apoptosis in INS-1 cells","volume":"899","author":"Liu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175776_bib93","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2009.141","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009","volume":"45","author":"Ljungman","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejphar.2023.175776_bib94","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2005.05.007","article-title":"Nuclear interaction of EGFR and STAT3 in the activation of the iNOS\/NO pathway","volume":"7","author":"Lo","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2023.175776_bib95","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1182\/blood-2008-03-147322","article-title":"STAT-3 and ERK 1\/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib96","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2019.12.017","article-title":"Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis","volume":"318","author":"Luo","year":"2020","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.ejphar.2023.175776_bib97","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s10637-019-00724-4","article-title":"Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma","volume":"37","author":"Luo","year":"2019","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejphar.2023.175776_bib98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2011.01.008","article-title":"Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3","volume":"268","author":"Ma","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib99","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/annonc\/mdp252","article-title":"Epidemiology of invasive cutaneous melanoma","volume":"20","author":"MacKie","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2023.175776_bib100","series-title":"Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis, Mayo Clinic Proceedings","first-page":"364","author":"Markovic","year":"2007"},{"key":"10.1016\/j.ejphar.2023.175776_bib101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.10.32","article-title":"Pathogenesis and diagnosis of hepatic encephalopathy","volume":"4","author":"McPhail","year":"2010","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2023.175776_bib102","doi-asserted-by":"crossref","first-page":"515","DOI":"10.5435\/00124635-200908000-00005","article-title":"Osteosarcoma","volume":"17","author":"Messerschmitt","year":"2009","journal-title":"JAAOS - Journal of the American Academy of Orthopaedic Surgeons"},{"key":"10.1016\/j.ejphar.2023.175776_bib103","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00439-009-0715-9","article-title":"Genetic risk factors for melanoma","volume":"126","author":"Meyle","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejphar.2023.175776_bib104","doi-asserted-by":"crossref","first-page":"18074","DOI":"10.1021\/acsami.9b01343","article-title":"Pro-nifuroxazide self-assembly leads to triggerable nanomedicine for anti-cancer therapy","volume":"11","author":"Misra","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejphar.2023.175776_bib105","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2023.175776_bib106","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1572-0241.2005.40615.x","article-title":"Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases","volume":"100","author":"Mudter","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2023.175776_bib107","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1097\/TP.0000000000001406","article-title":"Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management","volume":"100","author":"Murali","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2023.175776_bib108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jmb.2016.01.003","article-title":"Allosteric communication across STAT3 domains associated with STAT3 function and disease-causing mutation","volume":"428","author":"Namanja","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib109","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/MCB.21.19.6615-6625.2001","article-title":"Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells","volume":"21","author":"Narimatsu","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107931","article-title":"Nifuroxazide mitigates cholestatic liver injury by synergistic inhibition of Il-6\/\u0392-catenin signaling and enhancement of BSEP and MDRP(2) expression","volume":"99","author":"Nazmy","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2023.175776_bib111","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1182\/blood-2007-12-129718","article-title":"Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3","volume":"112","author":"Nelson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib112","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/aps.2014.42","article-title":"Inhibition of STAT3 acetylation is associated with angiotensin renal fibrosis in the obstructed kidney","volume":"35","author":"Ni","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.175776_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/invivo.11019","article-title":"Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies","volume":"31","author":"Nogueira","year":"2017","journal-title":"In Vivo"},{"key":"10.1016\/j.ejphar.2023.175776_bib114","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5152\/tjg.2019.18389","article-title":"Potential effects of xylopic acid on acetic acid-induced ulcerative colitis in rats","volume":"30","author":"Osafo","year":"2019","journal-title":"Turk. J. Gastroenterol. : the official journal of Turkish Society of Gastroenterology"},{"key":"10.1016\/j.ejphar.2023.175776_bib115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00595-018-1661-8","article-title":"Colon cancer with perforation","volume":"49","author":"Otani","year":"2019","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejphar.2023.175776_bib116","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/dom.13207","article-title":"Have we really demonstrated the cardiovascular safety of anti-hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetes","volume":"20","author":"Packer","year":"2018","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2023.175776_bib117","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cytogfr.2008.08.006","article-title":"The many faces of the SOCS box","volume":"19","author":"Piessevaux","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2023.175776_bib118","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cytogfr.2015.07.010","article-title":"Mutations leading to constitutive active gp130\/JAK1\/STAT3 pathway","volume":"26","author":"Pilati","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2023.175776_bib119","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/db08-0061","article-title":"From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy","volume":"57","author":"Qian","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.175776_bib121","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.0903006","article-title":"STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatouss graft-versus-host disease in a murine model","volume":"184","author":"Radojcic","year":"2010","journal-title":"J. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2023.175776_bib122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: every year a new standard?","volume":"37","author":"Rajkumar","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2023.175776_bib123","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.onc.1204186","article-title":"G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation","volume":"20","author":"Ram","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2023.175776_bib124","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mc.2940070303","article-title":"How many mutations are required for tumorigenesis? Implications from human cancer data","volume":"7","author":"Renan","year":"1993","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejphar.2023.175776_bib125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/bcpt.12313","article-title":"Novel points of attack for targeted cancer therapy","volume":"116","author":"R\u00f8sland","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2023.175776_bib126","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.taap.2018.12.020","article-title":"Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NF\u03baB and Nrf-2\/HO-1 signaling crosstalk","volume":"364","author":"Saber","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175776_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112731","article-title":"Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-\u03baB signaling: a new challenge for unmet therapeutic needs","volume":"148","author":"Saber","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175776_bib128","first-page":"63","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med. Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbi.2017.12.030","article-title":"Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats","volume":"281","author":"Said","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2023.175776_bib130","doi-asserted-by":"crossref","first-page":"21087","DOI":"10.3390\/ijms141021087","article-title":"Cancer development, progression, and therapy: an epigenetic overview","volume":"14","author":"Sarkar","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175776_bib131","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.chembiol.2018.09.005","article-title":"ALDH1 bio-activates nifuroxazide to eradicate ALDH(high) melanoma-initiating cells","volume":"25","author":"Sarvi","year":"2018","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/j.ejphar.2023.175776_bib132","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12297","article-title":"Therapeutic potential of Myrtus communis subsp. communis extract against acetic acid\u2010induced colonic inflammation in rats","volume":"41","author":"Sen","year":"2017","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ejphar.2023.175776_bib133","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3748\/wjg.v16.i27.3347","article-title":"Changing face of hepatic encephalopathy: role of inflammation and oxidative stress","volume":"16","author":"Seyan","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2023.175776_bib134","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.intimp.2019.02.038","article-title":"A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41\/43 respectors","volume":"71","author":"Shao","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2023.175776_bib135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021. CA","volume":"71","author":"Siegel","year":"2021","journal-title":"A Cancer Journal for Clinicians"},{"key":"10.1016\/j.ejphar.2023.175776_bib136","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2013-12-543736","article-title":"Activity of therapeutic JAK 1\/2 blockade in graft-versus-host disease","volume":"123","author":"Spoerl","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175776_bib137","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2023.175776_bib138","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-98-4-461","article-title":"Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings","volume":"98","author":"Storb","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","article-title":"Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics","volume":"15","author":"Talevi","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2023.175776_bib141","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/697010","article-title":"Diabetic kidney disease: pathophysiology and therapeutic targets","volume":"2015","author":"Toth-Manikowski","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2023.175776_bib142","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11094-005-0161-5","article-title":"Hydrolytic and reductive transformations of nifuroxazide","volume":"39","author":"Trukhacheva","year":"2005","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejphar.2023.175776_bib143","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10565-019-09499-z","article-title":"Down-regulation of aryl hydrocarbon receptor intensifies carcinogen-induced retinal lesion via SOCS3-STAT3 signaling","volume":"36","author":"Tsai","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejphar.2023.175776_bib144","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175776_bib145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib146","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.ejphar.2023.175776_bib147","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejphar.2023.175776_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108911","article-title":"Nifuroxazide in combination with CpG ODN exerts greater efficacy against hepatocellular carcinoma","volume":"108","author":"Wang","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2023.175776_bib149","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/jb.56.5.649-652.1948","article-title":"A comparative study of the in vitro bacteriostatic action of some simple derivatives of furan, thiophene, and pyrrole","volume":"56","author":"Ward","year":"1948","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejphar.2023.175776_bib150","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.27968","article-title":"Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma","volume":"62","author":"Won","year":"2015","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.ejphar.2023.175776_bib151","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/np4006772","article-title":"Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis","volume":"76","author":"Xiao","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2023.175776_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.63","article-title":"Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib153","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.939.65.3","article-title":"Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175776_bib154","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ibd\/izz149","article-title":"Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer","volume":"25","author":"Yao","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.452","article-title":"Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis","volume":"8","author":"Ye","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib156","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41419-019-1955-9","article-title":"Correction: inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis","volume":"10","author":"Ye","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175776_bib157","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer--new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2023.175776_bib158","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2023.175776_bib159","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2023.175776_bib160","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib161","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1128\/MCB.20.19.7132-7139.2000","article-title":"The coiled-coil domain of Stat3 is essential for its SH2 domain-mediated receptor binding and subsequent activation induced by epidermal growth factor and interleukin-6","volume":"20","author":"Zhang","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175776_bib162","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.08.58","article-title":"Vasoactive agents for the treatment of sepsis","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejphar.2023.175776_bib163","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/jcb.29432","article-title":"Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy","volume":"121","author":"Zhao","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2023.175776_bib164","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3892\/or.2017.5629","article-title":"Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma","volume":"37","author":"Zhao","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2023.175776_bib165","article-title":"Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300287X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300287X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:18:45Z","timestamp":1757978325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992300287X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":164,"alternative-id":["S001429992300287X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175776","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175776"}}